Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

63%

5 trials in Phase 3/4

Results Transparency

0 of 4 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

Phase 4

5(62.5%)

N/A

2(25.0%)

Phase 1

1(12.5%)

8Total

Phase 4(5)

N/A(2)

Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT02044250Phase 4Completed

Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis- EXtended Antiplatelet Monotherapy (HOST-EXAM)

Role: collaborator

NCT05845489Phase 4Recruiting

Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis- CloPidogREl for Primary preVENTION (HOST-PREVENTION)

Role: collaborator

NCT06767345Phase 4Recruiting

Comparison of Moderate-Intensity Statin Plus Ezetimibe vs. High-Intensity Statin for Coronary Plaque Stabilization

Role: collaborator

NCT03611725Not ApplicableCompleted

Comparison of Success Rate Between Distal Radial Approach and Radial Approach in STEMI

Role: collaborator

NCT03169985Phase 4Active Not Recruiting

Randomized Controlled Trial of Moderate-Intensity Rosuvastatin With Ezetimibe Combination Therapy Versus High-Intensity Rosuvastatin on Progression of Coronary Atherosclerotic Plaque

Role: collaborator

NCT06649240Not ApplicableRecruiting

Optimal Target Low-density Lipoprotein Cholesterol Level for Small Vessel Occlusion Stroke

Role: collaborator

NCT03912285Phase 1Completed

The Pharmacokinetic Interaction Between Amlodipine and Losartan

Role: collaborator

NCT01584791Phase 4Completed

Korean Multicenter Randomized Controlled Trial (RCT) of Pidogul for Patients With Coronary Stenting

Role: collaborator

All 8 trials loaded